Aurobindo Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

2,894.03

2,692.03

2,668.76

2,390.82

3,547.44

Operating profit

774.79

481.69

545.18

422.38

691.83

Interest

53.07

61.25

36.69

31.59

48.97

Gross profit

844.69

751.57

575.57

485.67

931.03

EPS (Rs)

9.88

10.65

7.10

5.73

11.01

Other income

122.97

331.13

67.08

94.88

288.17

Stock adjustment

-13.10

-59.76

-27.12

-16.25

-260.97

Raw material

1,401.56

1,465.93

1,518.33

1,375.26

2,057.46

Power and fuel

-

-

-

-

-

Employee expenses

248.91

248.08

247.51

236.06

406.77

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

481.87

556.09

384.86

373.37

652.35

Provisions made

-

-

-

-

-

Depreciation

64.81

64.35

65.79

59.63

115.00

Taxation

201.21

63.44

130.13

90.09

171.23

Net profit / loss

578.67

623.78

415.74

335.95

644.80

Extra ordinary item

-

-

36.09

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

58.59

58.59

58.59

58.59

58.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.77

17.89

20.43

17.67

19.50

GPM (%)

28.00

24.86

21.04

19.54

24.27

NPM (%)

19.18

20.63

15.20

13.52

16.81